Ipca Labs.

IPCALAB16 Apr 2024
Pharmaceuticals
₹
+14.60 (+1.10%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
BUY
SELL
To Invest in Ipca Labs.
Ipca Labs.
Pharmaceuticals
IPCALAB16 Apr 2024
₹
+14.60 (+1.10%)
OverviewFundamentalsFuturesOptions
1D
1M
6M
1Y
5Y
All

Ipca Labs. - Share Price & Details

Lowest Today
1316.8
Highest Today
1360
Today’s Open
1324.35
Prev. Close
1327.25
52 Week High
1360
52 Week Low
670
Traded Volume
₹
Market Cap(Cr)
Avg Traded Price
1 Year return
61.97%
Upper Circuit
Lower Circuit
P/E TTM
61.16
P/B Ratio
5.43
Traded Value(Cr)
0.00
EPS TTM
21.7
Book value
Dividend
0.30%

Price Performance

1.98 %
1 Wk
13.73 %
1 M
17.95 %
3 M
61.97 %
1 Y
19.68 %
YTD

Traded Volume Movement

Technical Details

Support 3
1274
Support 2
1295
Support 1
1319
Pivot Point :
1340
Resistance 1
1363
Resistance 2
1385
Resistance 3
1408

Reports

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Ipca Laboratories Ltd
₹1,341.85(+14.60/1.10%)
1,341.85+14.6033,672.8961.9761.165.43
Astrazeneca Pharma India Ltd
₹5,288.60(+96.20/1.85%)
5,288.60+96.2012,981.0066.0581.3919.82
Cipla Ltd
₹1,376.05(-5.20/-0.38%)
1,376.05-5.20111,517.5852.0933.914.31
Bliss GVS Pharma Ltd
₹112.15(+2.00/1.82%)
112.15+2.001,153.1749.3116.891.18
Abbott India Ltd
₹26,091.35(-97.95/-0.37%)
26,091.35-97.9555,652.2616.8748.5817.90
Amrutanjan Health Care Ltd
₹648.60(-9.30/-1.41%)
648.60-9.301,902.037.1943.237.26

About Ipca Laboratories Ltd

Ipca Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 33672.89 crores. It has reported a sales of Rs. 1506.83 crores and a net profit of Rs. 136.94 crores for the quarter ended December 2018. The company management includes Premchand Godha, Premchand Godha,A K Jain,Pranay Godha,Prashant Godha,Anand T Kusre,Manisha Premnath,Kamal Kishore Seth,Narendra Mairpady,Harish P Kamath (Ipca Laboratories Ltd) among others.
Chairman
Premchand Godha
Registered office
48 Kandivli Industrial Estate,Kandivli (West),Mumbai,Maharashtra,400067
FAX :91-22-28686613
Background
Incorporation Year1949
Face Value₹1
Market Lot1

Latest News

Technical View: Nifty forms bullish candle, 22,000 is the level to watch
The Nifty ended lower for a third straight session on April 16, tracking weakness in global markets as worries over the worsening situation in West Asia weighed on sentiment. After opening lower, the index sank to the day’s low of 22,079. It narrowed the losses later in the session to end 125 points lower at 22,148. It formed a small bullish candlestick with upper and lower shadows.
16 Apr 2024 | 05:19 PM
Nifty IT index tumbles over 2.5% to hit new 2024 low on fading Fed rate
Indian IT stocks faced persistent selling pressure in today's trading session. Starting with the opening bell, the stocks experienced downward momentum, resulting in the Nifty IT index plummeting by 2.57% to reach an intraday low of 33,576 points, hitting the lowest level in CY24.The sharp decline in stocks reflects a broader market trend of selling pressure, exacerbated by escalating tensions.
16 Apr 2024 | 04:06 PM
📢 Sensex declines 457 points at the close; Nifty ends above 21,150
📈 Domestic benchmark indices closed on a negative note on 16-April-2024
📢 At 3:30 PM, the Sensex tanked by 456.10 points or 0.62% at 72,943.68, and the
Nifty was down 124.60 points or 0.56% at 22,147.90.
📊Among sectoral, Nifty FMCG (⬆️0.43%) turned out to be the best performer while Nifty IT (⬇️2.58%) saw considerable selling.
16 Apr 2024 | 03:42 PM
📢 Sensex plunges 427 points at the open; Nifty below 22,200
📈 Amid weak global cues, domestic benchmark indices started gap-down on 16th April 2024.
📢 At 9:16 AM, the Sensex tanked 427.88 points or 0.58% at 72,971.90, and the Nifty plunged 11.50 points or 0.51% at 22,158.00.
📊Vodafone Idea(⬇️3.04%), Metropolis(⬇️1.93%) and Apollo Tyres(⬇️1.92%) appeared as the top losers on the Nifty 50 at the Open. Zee Entertain, Exide Ind are in focus today.
16 Apr 2024 | 09:27 AM
Technical View: Nifty forms bullish candle, 22,000 is the level to watch
The Nifty ended lower for a third straight session on April 16, tracking weakness in global markets as worries over the worsening situation in West Asia weighed on sentiment. After opening lower, the index sank to the day’s low of 22,079. It narrowed the losses later in the session to end 125 points lower at 22,148. It formed a small bullish candlestick with upper and lower shadows.
16 Apr 2024 | 05:19 PM
view more news

How to buy Ipca Labs. shares on nse?

To buy Ipca Labs. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Ipca Labs. share price today?

The Ipca Labs. shares price on nse is Rs.1341.85 today.

What is the market cap of Ipca Labs. shares on BSE ?

The company has a market capitalization of Rs.33672.89Cr

What is the PE & PB ratio of Ipca Labs. shares ?

PE is 61.16 and PB is 5.43

What is the 52 Week High and Low of Ipca Labs. shares?

Ipca Labs. stock price high: Rs.1360 Ipca Labs. stock price low: Rs.670

Is Ipca Labs a government-run institution?

No, IPCA Laboratories is not a government-run organization. It is a privately-owned pharmaceutical company based in India. IPCA Laboratories was founded in 1949 and has since grown to become one of the leading pharmaceutical companies in India.

Who is Ipca Labs’ owner?

IPCA Laboratories is a publicly-traded company and its ownership is spread among its shareholders. The Promoter of IPCA Labs is Mr. Premchand Godha and his family.

How well is Ipca Labs doing?

IPCA Laboratories operates in the pharmaceutical industry and has a diverse product portfolio that includes medicines for various therapeutic segments, including antimalarials, anti-bacterial, pain management, and cardiovascular drugs.

Ipca Labs’ consolidated revenue has gone from Rs. 3773.18 crores in March 2019 to  Rs. 5,829.79 crores on 31 March 2022. The net profit has gone from Rs. 443.03 crores to Rs. 910.95 crores in the same period.

Ipca Labs stock has given a positive return of 10.05% over the past three years and a negative return of -18.57% over the past one year.

 

What are the latest results of Ipca Labs?

The last fiscal result of Ipca Labs was declared in March 2022 and they reported a consolidated revenue of INR 5,829.79 crore and net profit of Rs. 910.95 crores.

What are the potential catalysts that positively impact the stock price of Ipca lab?

Some potential catalysts that may positively affect IPCA Laboratories' stock price could include:

  • Strong financial results
  • Expansion in new markets
  • Launch of new products
  • Regulatory approvals
  • Industry trends
BUY
SELL